Epidemiology of HIV Among Injecting and Non-injecting Drug Users: Current Trends and Implications for Interventions
Tóm tắt
Từ khóa
Tài liệu tham khảo
• Mathers BM, Degenhardt L, Phillips B, et al.: Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet 2008, 372:1733–1745. This is a global summary estimating the number of IDUs by country and region and the proportion who are HIV-positive among them.
United Nations Office on Drugs and Crime: World Drug Report. New York; 2009.
Ministry of Health of Ukraine: National report on monitoring progress towards the UNGLASS (United National General Assembly Special Session) declaration of commitment on HIV/AIDS. Available at: http://www.unaids.org/en/CountryResponses/Countries/ukraine.asp . Accessed February 2010.
World Bank/International HIV/AIDS Alliance in Ukraine: Socioeconomic Impact of HIV/AIDS in Ukraine. Washington, DC: Library of Congress; 2006.
Niccolai LM, Shcherbakova IS, Toussova OV, et al.: The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health 2009, 86(Suppl 1):131–143.
Mathers B, Degenhardt L, Ali H, et al.: HIV prevention, treatment and care services for people who inject drugs: a systematic review of global, regional and country level coverage. Lancet 2010, 375:1014–1028.
Reid SR: Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J 2009, 6:24.
Gelmon L, Kenya P, Oguya F, et al.: Kenya HIV prevention response and modes of transmission (MOT) analysis. UNAIDS. Available at: http://www.unaidsrstesa.org/files/u1/Kenya_MoT_Country_Synthesis_Report_22Mar09.pdf . Accessed September 2009.
Williams ML, McCurdy SA, Bowen AM, et al.: HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Educ Prev 2009, 21:474–483.
Burris S, Corey SD: A blueprint for reforming access to opioid medications. Social Science Research Network. Available at: http://ssrn.com/abstract=1356815 . Accessed September 2009.
Centers for Disease Control and Prevention (CDC): HIV-associated behaviors among injecting-drug users—23 Cities, United States, May 2005–February 2006. MMWR Morb Mortal Wkly Rep 2009, 58:329–332
Centers for Disease Control and Prevention (CDC): HIV infection among injection-drug users—34 states, 2004–2007. MMWR Morb Mortal Wkly Rep 2009, 58:1291–1295
Centers for Disease Control and Prevention: HIV/AIDS Surveillance in Injection Drug Users (through 2007). Available at: https://www.cdc.gov/hiv/idu/resources/index.htm . Accessed November 2009.
• Broz D, Ouellet LJ: Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend 2008, 94:221–233. This article describes the changing landscape of injection drug use patterns by ethnic group in the United States.
Des Jarlais DC, Arasteh K, Perlis T, et al.: Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007, 21:231–235
Panda S, Chatterjee A, Bhattacharya SK, et al.: Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS 2000, 11:468–473.
Hacker MA, Leite I, Friedman SR, et al.: Poverty, bridging between injecting drug users and the general population, and “interiorization” may explain the spread of HIV in southern Brazil. Health Place 2009, 15:514–519.
Strathdee SA, Sherman SG: The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health 2003, 80:iii7–iii14.
Bassols AM, Santos RA, Rohde LA, Pechansky F: Exposure to HIV in Brazilian adolescents: the impact of psychiatric symptomatology. Eur Child Adolesc Psychiatry 2007, 16:236–242.
Strathdee SA, Lozada R, Ojeda VD, et al.: Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One 2008, 3:e2690.
Deiss R: Prevalence and correlates of HIV infection among non-injection drug users in Tijuana, Mexico. Submitted 2010.
Wang H, Chen RY, Ding G, et al.: Prevalence and predictors of HIV infection among female sex workers in Kaiyuan City, Yunnan Province, China. Int J Infect Dis 2009, 13:162–169.
Patterson TL, Semple SJ, Staines H, et al.: Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. J Infect Dis 2008, 197:728–732.
Sherman SG, Latkin CA: Intimate relationship characteristics associated with condom use among drug users and their sex partners: a multilevel analysis. Drug Alcohol Depend 2001, 64:97–104.
Aaron S, McMahon JM, Milano D, et al.: Intranasal transmission of hepatitis C virus: virological and clinical evidence. Clin Infect Dis 2008, 47:931–934.
Tortu S, McMahon JM, Pouget ER, Hamid R: Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse 2004, 39:211–224.
Edlin BR, Irwin KL, Faruque S, et al.: Intersecting epidemics—crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med 1994, 331:1422–1427.
de Souza CT, Diaz T, Sutmoller F, Bastos FI: The association of socioeconomic status and use of crack/cocaine with unprotected anal sex in a cohort of men who have sex with men in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2002, 29:95–100.
Hacker MA, Malta M, Enriquez M, Bastos FI: Human immunodeficiency virus, AIDS, and drug consumption in South America and the Caribbean: epidemiological evidence and initiatives to curb the epidemic. Rev Panam Salud Publica 2005, 18:303–313.
Strathdee SA, Philbin MM, Semple SJ, et al.: Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend 2008, 92:132–140.
Lau JT, Tsui HY, Zhang Y, et al.: Comparing HIV-related syringe-sharing behaviors among female IDU engaging versus not engaging in commercial sex. Drug Alcohol Depend 2008, 97:54–63.
Degenhardt L, Mathers B, Guarinieri M, et al.: Meth/amphetamine use and associated HIV: Implications for global policy and public health. Int J Drug Policy 2010, In press.
Shoptaw S, Reback CJ: Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction 2007, 102(Suppl 1):130–135.
Rawstorne P, Digiusto E, Worth H, Zablotska I: Associations between crystal methamphetamine use and potentially unsafe sexual activity among gay men in Australia. Arch Sex Behav 2007, 36:646–654.
Semple SJ, Zians J, Strathdee SA, Patterson TL: Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav 2009, 38:583–590.
Semple SJ, Strathdee SA, Zians J, Patterson TL: Sexual risk behavior associated with co-administration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men. Am J Addict 2009, 18:65–72.
Drumright LN, Patterson TL, Strathdee SA: Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse 2006, 41:1551–1601.
Toussi SS, Joseph A, Zheng JH, et al.: Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication. AIDS Res Hum Retroviruses 2009, 25:1117–1121.
Cachay ER, Moini N, Kosakovsky Pond SL, et al.: Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. Open AIDS J 2007, 1:5–10
Friedman SR, Des Jarlais DC: HIV among drug injectors: the epidemic and the response. AIDS Care 1991, 3:239–250.
Vlahov D, Robertson AM, Strathdee SA: HIV prevention among injection drug users in resource-limited settings. Clin Infect Dis 2010, In press.
Metzger DS, Navaline H: HIV prevention among injection drug users: the need for integrated models. J Urban Health 2003, 80:iii59–iii66
Des Jarlais DC, McKnight C, Goldblatt C, Purchase D: Doing harm reduction better: syringe exchange in the United States. Addiction 2009, 104:1441–1446
Wood E, Kerr T, Marshall BD, et al.: Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009, 338:b1649.
Malta M, Magnanini MM, Strathdee SA, Bastos FI: Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 2008 Nov 20 (Epub ahead of print).
Malta M, Strathdee SA, Magnanini MM, Bastos FI: Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 2008, 103:1242–1257.
Kerr T, Kimber J, Debeck K, Wood E: The role of safer injection facilities in the response to HIV/AIDS among injection drug users. Curr HIV/AIDS Rep 2007, 4:158–164.
Mausbach BT, Semple SJ, Strathdee SA, et al.: Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-negative, heterosexual methamphetamine users: results from the Fast-Lane Study. Ann Behav Med 2007, 34:263–274.